Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic


Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2021
Historique:
received: 27 06 2021
accepted: 29 07 2021
entrez: 7 9 2021
pubmed: 8 9 2021
medline: 15 2 2022
Statut: epublish

Résumé

The occurrence of different subtypes of endogenous Cushing's syndrome (CS) in single individuals is extremely rare. We here present the case of a female patient who was successfully cured from adrenal CS 4 years before being diagnosed with Cushing's disease (CD). The patient was diagnosed at the age of 50 with ACTH-independent CS and a left-sided adrenal adenoma, in January 2015. After adrenalectomy and histopathological confirmation of a cortisol-producing adrenocortical adenoma, biochemical hypercortisolism and clinical symptoms significantly improved. However, starting from 2018, the patient again developed signs and symptoms of recurrent CS. Subsequent biochemical and radiological workup suggested the presence of ACTH-dependent CS along with a pituitary microadenoma. The patient underwent successful transsphenoidal adenomectomy, and both postoperative adrenal insufficiency and histopathological workup confirmed the diagnosis of CD. Exome sequencing excluded a causative germline mutation but showed somatic mutations of the β-catenin protein gene (

Identifiants

pubmed: 34489873
doi: 10.3389/fendo.2021.731579
pmc: PMC8417750
doi:

Substances chimiques

CTNNB1 protein, human 0
Endosomal Sorting Complexes Required for Transport 0
NR3C1 protein, human 0
Receptors, Glucocorticoid 0
beta Catenin 0
Endopeptidases EC 3.4.-
USP8 protein, human EC 3.4.19.12
Ubiquitin Thiolesterase EC 3.4.19.12

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

731579

Informations de copyright

Copyright © 2021 Detomas, Altieri, Schlötelburg, Appenzeller, Schlaffer, Coras, Schirbel, Wild, Kroiss, Sbiera, Fassnacht and Deutschbein.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cancer Cell. 2016 May 9;29(5):723-736
pubmed: 27165744
J Clin Endocrinol Metab. 2016 Sep;101(9):3526-38
pubmed: 27389594
Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101434
pubmed: 32622829
Clin Endocrinol (Oxf). 2002 Nov;57(5):657-62
pubmed: 12390341
Clin Epidemiol. 2015 Apr 17;7:281-93
pubmed: 25945066
Cancers (Basel). 2019 Nov 08;11(11):
pubmed: 31717455
Bioinformatics. 2009 Sep 1;25(17):2283-5
pubmed: 19542151
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Trends Endocrinol Metab. 2015 Oct;26(10):573-583
pubmed: 26412158
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Hum Pathol. 2021 Apr;110:50-61
pubmed: 33058949
Endocr Pract. 2011 Nov-Dec;17(6):941-8
pubmed: 21742609
N Engl J Med. 1988 Apr 14;318(15):966-70
pubmed: 2832758
J Endocr Soc. 2017 May 30;1(7):918-925
pubmed: 29264542
J Clin Endocrinol Metab. 2011 Feb;96(2):E419-26
pubmed: 21084400
Endocr Relat Cancer. 2018 Mar;25(3):R131-R152
pubmed: 29233839
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5651-5657
pubmed: 31276155
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
J Endocrinol Invest. 2006 Nov;29(10):934-9
pubmed: 17185905
J Clin Endocrinol Metab. 2008 May;93(5):1526-40
pubmed: 18334580
Endocrine. 2019 Feb;63(2):240-246
pubmed: 30315484
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Endocr Relat Cancer. 2019 Oct 01;26(10):R567-R581
pubmed: 32053747
Eur J Endocrinol. 2017 May;176(5):R205-R216
pubmed: 28179447
Development. 2008 Aug;135(15):2593-602
pubmed: 18599507
Nat Genet. 2015 Jan;47(1):31-8
pubmed: 25485838
Endocr Rev. 2014 Apr;35(2):282-326
pubmed: 24423978
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
J Clin Endocrinol Metab. 1984 Jan;58(1):25-31
pubmed: 6315761
J Endocr Soc. 2019 Feb 20;3(4):763-772
pubmed: 30963134
Cancers (Basel). 2020 Feb 04;12(2):
pubmed: 32033200
Acta Med Port. 2010 Jan-Feb;23(1):107-12
pubmed: 20353713
Nat Protoc. 2016 Dec;11(12):2529-2548
pubmed: 27854363
Nat Biotechnol. 2011 Jan;29(1):24-6
pubmed: 21221095
J Clin Endocrinol Metab. 2015 Aug;100(8):3165-71
pubmed: 26147609
J Clin Endocrinol Metab. 2020 Dec 1;105(12):
pubmed: 32875319
Medicina (B Aires). 2015;75(4):218-20
pubmed: 26339876
Mol Cell Endocrinol. 2002 Nov 29;197(1-2):69-72
pubmed: 12431798
J Clin Endocrinol Metab. 1980 May;50(5):961-6
pubmed: 6246139
Lancet. 2015 Aug 29;386(9996):913-27
pubmed: 26004339
Endocr Relat Cancer. 2021 Jan;28(1):79-95
pubmed: 33151900

Auteurs

Mario Detomas (M)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Barbara Altieri (B)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Wiebke Schlötelburg (W)

Department of Diagnostic and Interventional Radiology, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.
Department of Nuclear Medicine, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Silke Appenzeller (S)

Core Unit Bioinformatics, Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, University of Würzburg, Würzburg, Germany.

Sven Schlaffer (S)

Department of Neurosurgery, University Hospital Erlangen, Erlangen, Germany.

Roland Coras (R)

Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany.

Andreas Schirbel (A)

Department of Nuclear Medicine, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Vanessa Wild (V)

Institute of Pathology, University of Würzburg, Würzburg, Germany.

Matthias Kroiss (M)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.
Department of Internal Medicine IV, University Hospital Munich, Ludwig-Maximilians-Universität München, Munich, Germany.

Silviu Sbiera (S)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Martin Fassnacht (M)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.

Timo Deutschbein (T)

Department of Internal Medicine I, Division of Endocrinology and Diabetes, University Hospital Würzburg, University of Würzburg, Würzburg, Germany.
Medicover Oldenburg MVZ, Oldenburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH